rs34380494
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_004268.5(MED17):c.1482A>G(p.Gln494Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00211 in 1,601,822 control chromosomes in the GnomAD database, including 65 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 33 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 32 hom. )
Consequence
MED17
NM_004268.5 synonymous
NM_004268.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.85
Publications
2 publications found
Genes affected
MED17 (HGNC:2375): (mediator complex subunit 17) The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. [provided by RefSeq, Jul 2008]
MED17 Gene-Disease associations (from GenCC):
- infantile cerebral and cerebellar atrophy with postnatal progressive microcephalyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 11-93807533-A-G is Benign according to our data. Variant chr11-93807533-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 129595.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.85 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0111 (1695/152316) while in subpopulation AFR AF = 0.0378 (1570/41564). AF 95% confidence interval is 0.0362. There are 33 homozygotes in GnomAd4. There are 811 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 33 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MED17 | ENST00000251871.9 | c.1482A>G | p.Gln494Gln | synonymous_variant | Exon 10 of 12 | 1 | NM_004268.5 | ENSP00000251871.3 | ||
ENSG00000284057 | ENST00000638767.1 | c.2043A>G | p.Gln681Gln | synonymous_variant | Exon 17 of 19 | 5 | ENSP00000492220.1 |
Frequencies
GnomAD3 genomes AF: 0.0111 AC: 1687AN: 152200Hom.: 33 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1687
AN:
152200
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00305 AC: 767AN: 251370 AF XY: 0.00248 show subpopulations
GnomAD2 exomes
AF:
AC:
767
AN:
251370
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00117 AC: 1689AN: 1449506Hom.: 32 Cov.: 28 AF XY: 0.00115 AC XY: 828AN XY: 722030 show subpopulations
GnomAD4 exome
AF:
AC:
1689
AN:
1449506
Hom.:
Cov.:
28
AF XY:
AC XY:
828
AN XY:
722030
show subpopulations
African (AFR)
AF:
AC:
1185
AN:
33144
American (AMR)
AF:
AC:
90
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26042
East Asian (EAS)
AF:
AC:
3
AN:
39586
South Asian (SAS)
AF:
AC:
205
AN:
86006
European-Finnish (FIN)
AF:
AC:
2
AN:
53404
Middle Eastern (MID)
AF:
AC:
13
AN:
5750
European-Non Finnish (NFE)
AF:
AC:
61
AN:
1100886
Other (OTH)
AF:
AC:
130
AN:
59984
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
76
152
229
305
381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0111 AC: 1695AN: 152316Hom.: 33 Cov.: 32 AF XY: 0.0109 AC XY: 811AN XY: 74476 show subpopulations
GnomAD4 genome
AF:
AC:
1695
AN:
152316
Hom.:
Cov.:
32
AF XY:
AC XY:
811
AN XY:
74476
show subpopulations
African (AFR)
AF:
AC:
1570
AN:
41564
American (AMR)
AF:
AC:
82
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
1
AN:
5184
South Asian (SAS)
AF:
AC:
11
AN:
4824
European-Finnish (FIN)
AF:
AC:
1
AN:
10616
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3
AN:
68034
Other (OTH)
AF:
AC:
26
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
84
168
253
337
421
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Apr 03, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Aug 17, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Jun 26, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.